NCT01013285View on ClinicalTrials.gov

Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2013

Study Completion Date

August 31, 2015

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

bevacizumab

DRUG

temozolomide

RADIATION

external beam radiation therapy

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, University of California, Los Angeles (UCLA), Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT01013285 - Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | Biotech Hunter | Biotech Hunter